TCIM
TIAA CREF Investment Management Portfolio holdings
AUM
$141B
This Quarter Return
+1.19%
1 Year Return
+14.2%
3 Year Return
+70.14%
5 Year Return
+108.44%
10 Year Return
–
AUM
$141B
AUM Growth
+$141B
(-1.9%)
Cap. Flow
-$2.02B
Cap. Flow
% of AUM
-1.44%
Top 10 Holdings %
Top 10 Hldgs %
13.67%
Holding
3,275
New
159
Increased
1,536
Reduced
1,509
Closed
51
Top Buys
| 1 |
Starbucks
SBUX
|
$344M |
| 2 |
Eli Lilly
LLY
|
$268M |
| 3 |
Amazon
AMZN
|
$237M |
| 4 |
PPG Industries
PPG
|
$209M |
| 5 |
AT&T
T
|
$194M |
Top Sells
| 1 |
Apple
AAPL
|
$333M |
| 2 |
Gilead Sciences
GILD
|
$242M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
$190M |
| 4 |
Tesla
TSLA
|
$183M |
| 5 |
Schlumberger
SLB
|
$152M |
Sector Composition
| 1 | Healthcare | 16.06% |
| 2 | Technology | 14.91% |
| 3 | Financials | 13.87% |
| 4 | Consumer Discretionary | 10.67% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Merck
MRK
$210B
| $914M | 0.65% | 16,052,902 -851,742 | -5% | -$48.5M |
|
27
Mastercard
MA
$538B
| $901M | 0.64% | 9,638,477 +740,796 | +8% | +$69.2M |
|
28
Citigroup
C
$178B
| $882M | 0.63% | 15,972,703 +805,557 | +5% | +$44.5M |
|
29
PepsiCo
PEP
$204B
| $882M | 0.63% | 9,446,666 -448,264 | -5% | -$41.8M |
|
30
Biogen
BIIB
$19.4B
| $865M | 0.61% | 2,141,512 +470,529 | +28% | +$190M |
|
31
Honeywell
HON
$139B
| $851M | 0.6% | 8,343,954 -139,631 | -2% | -$14.2M |
|
32
Chevron
CVX
$324B
| $807M | 0.57% | 8,364,369 -541,720 | -6% | -$52.3M |
|
33
3M
MMM
$82.8B
| $801M | 0.57% | 5,191,860 -58,343 | -1% | -$9M |
|
34
AbbVie
ABBV
$372B
| $797M | 0.57% | 11,859,727 -1,598,684 | -12% | -$107M |
|
35
IBM
IBM
$227B
| $772M | 0.55% | 4,748,340 -631,796 | -12% | -$103M |
|
|
TWX
36
DELISTED
Time Warner Inc
TWX
| $709M | 0.5% | 8,110,275 -293,599 | -3% | -$25.7M |
|
|
37
AT&T
T
$209B
| $708M | 0.5% | 19,925,273 +5,461,705 | +38% | +$194M |
|
38
Nike
NKE
$114B
| $701M | 0.5% | 6,488,921 +399,844 | +7% | +$43.2M |
|
39
Union Pacific
UNP
$133B
| $677M | 0.48% | 7,094,368 -1,104,279 | -13% | -$105M |
|
40
Amgen
AMGN
$155B
| $674M | 0.48% | 4,390,332 -341,448 | -7% | -$52.4M |
|
|
41
Eli Lilly
LLY
$657B
| $654M | 0.46% | 7,832,486 +3,212,309 | +70% | +$268M |
|
42
Coca-Cola
KO
$297B
| $651M | 0.46% | 16,594,440 -1,774,043 | -10% | -$69.6M |
|
|
43
Starbucks
SBUX
$100B
| $630M | 0.45% | 11,746,416 +6,417,364 | +120% | +$344M |
|
44
Intel
INTC
$107B
| $628M | 0.45% | 20,637,978 -2,759,434 | -12% | -$83.9M |
|
45
Bristol-Myers Squibb
BMY
$96B
| $612M | 0.43% | 9,201,745 -603,293 | -6% | -$40.1M |
|
46
EOG Resources
EOG
$68.2B
| $597M | 0.42% | 6,814,258 -1,004,105 | -13% | -$87.9M |
|
47
Salesforce
CRM
$245B
| $594M | 0.42% | 8,532,293 -163,375 | -2% | -$11.4M |
|
48
UnitedHealth
UNH
$281B
| $594M | 0.42% | 4,867,279 +769,746 | +19% | +$93.9M |
|
49
Adobe
ADBE
$151B
| $561M | 0.4% | 6,923,320 +76,183 | +1% | +$6.17M |
|
|
ALXN
50
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $559M | 0.4% | 3,090,822 +730,651 | +31% | +$132M |
|